The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies. (2021)
Attributed to:
Identifying the prevalence of antibodies to neuronal membrane targets in first episode psychosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.schres.2020.02.012
PubMed Identifier: 32295752
Publication URI: http://europepmc.org/abstract/MED/32295752
Type: Journal Article/Review
Volume: 234
Parent Publication: Schizophrenia research
ISSN: 0920-9964